Table 1 of
Szalai, Mol Vis 2012; 18:1927-1936.
Table 1. Immunolocalization of fibrillin-2, matrilin-2, matrilin-4, and tenascin-C in normal and stromal dystrophy corneas (maximum and minimum gray levels are 0 and 255, respectively).
| Control | Granular type I dystrophy | Lattice type I dystrophy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epithelium | Stroma | Epithelium | Stroma | Epithelium | Stroma | |||||||
| Antibody | Suprabasal | Basal | Subepithelial | Deep | Suprabasal | Basal | Subepithelial | Deep | Suprabasal | Basal | Subepithelial | Deep |
| Fibrillin-2 | 205.97±3.95 | 188.42±3.06 | 168.09±5.83 | 167.66±9.54 | 116.37±6.34 | 54.55±2.5 | 110.30±5.21 | 122.36±6.83 | 104.08±4.04 | 44.78±2.22 | 158.6±5.37 | 158.10±6.85 |
| p* | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.001 | 0.012 | ||||
| Tenascin-C | 165.49±5.50 | 140.41±5.29 | 163.9±5.54 | 223.25±3.79 | 110.12±5.68 | 49.39±2.27 | 100.58±5.75 | 100.69±5.11 | 150.93±4.62 | 102.91±5.3 | 163.34±7.47 | 156.8±6.19 |
| p* | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.912 | <0.0001 | ||||
| Matrilin-2 | 149.87±4.75 | 158.29±7.86 | 130.68±4.49 | 151.45±6.06 | 105.5±4.56 | 62.74±3.41 | 135.39±6.65 | 156.41±7.41 | 131.06±3.5 | 94.95±4.07 | 139.01±5.63 | 140.39±4.55 |
| P* | <0.0001 | <0.0001 | 0.248 | 0.190 | <0.0001 | <0.0001 | 0.002 | 0.0001 | ||||
| Matrilin-4 | 162.21±6.55 | 165.07±7.13 | 223.09±2.41 | 222.54±2.84 | 102.54±4.82 | 85.13±3.82 | 119.48±4.76 | 115.56±4.59 | 125.90±4.2 | 91.26±4.46 | 134.44±5.93 | 132.28±4.13 |
| P* | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | ||||